Delivery Order SPE2DB20D2104-SPE2DB25FMQQP
Award Date
5/11/25
Potential Completion Date
5/12/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,476.69 firm fixed-price contract is for the supply of the diabetes medication Mounjaro (5 mg/0.5 ml pen). The contract has a performance period through May 12, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,251.06 Firm Fixed Price delivery order is for the supply of the diabetes medication Mounjaro (12.5 mg/0.5 ml pen, 0.5 ml) with a period of performance through May 9, 2025. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,794.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The contract has a firm fixed price and an ultimate completion date of April 30, 2025. This contract is not designated as a set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award, valued at $1,088.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Mounjaro 15 mg/0.5 ml pens, a medication used to treat diabetes. This is a firm fixed-price delivery order contract with an ultimate completion date of April 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award, valued at $2,448.81, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which has a firm fixed price, is for the delivery of Mounjaro 10 mg/0.5 ml pens, a medication used to treat diabetes. The contract has an ultimate completion date of April 16, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,088.36 firm fixed-price contract is for the supply of the diabetes medication Mounjaro (5 mg/0.5 ml pen) and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,530.64 contract is for the supply of Mounjaro 5 mg/0.5 ml pens, a diabetes medication. The order has an ultimate completion date of April 16, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive...
This federal contract award, with ID SPE2DB22D2108|SPE2DB25FU4FK, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,740.84 firm fixed-price delivery order is for the supply of the diabetes medication Mounjaro 7.5 mg/0.5 ml pen. The contract has an ultimate completion date of April 29, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,308.65, is for the provision of the diabetes medication Mounjaro (7.5 mg/0.5 ml pen) to support military and government healthcare programs. The contract is a firm fixed-price delivery order, with an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,177.62 firm fixed-price contract is for the delivery of the diabetes medication MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of April 18, 2025 and is not set aside for any specific business category. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...